LEAMON CHRISTOPHER P (Chief Scientific Officer) received a stock award from FUSION PHARMACEUTICALS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/5/2024ACC: 0000950170-24-002301
Officer· Chief Scientific Officer
Since Nov 2021
+181.76K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
181.76K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+11.96K
Price / share
—
Trade value
—
% of position
New position
8/31/2023
0.00→11.96K
Total
Net shares
+11.96K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/31/2023 | A · Award | +11.96K | — | — | New position | 0.00 | 11.96K |
| Total | +11.96K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
106.10K shares
Shares
+106.10K
Strike price
8.44
Held after
106.10K
Exercisable
—
1/4/2024
Restricted Stock Units
Direct
Converts to
Common Stock
63.70K shares
Shares
+63.70K
Strike price
Held after
63.70K
Exercisable
—
1/4/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock106.10K shares | 1/4/2024 | A · Award | +106.10K | 8.44 | — | 106.10K |
| Restricted Stock Units Direct | Common Stock63.70K shares | 1/4/2024 | A · Award | +63.70K | — | 63.70K |